TR201000622A2 - Tiotropyum içeren farmasötik kombinasyonlar. - Google Patents

Tiotropyum içeren farmasötik kombinasyonlar.

Info

Publication number
TR201000622A2
TR201000622A2 TR2010/00622A TR201000622A TR201000622A2 TR 201000622 A2 TR201000622 A2 TR 201000622A2 TR 2010/00622 A TR2010/00622 A TR 2010/00622A TR 201000622 A TR201000622 A TR 201000622A TR 201000622 A2 TR201000622 A2 TR 201000622A2
Authority
TR
Turkey
Prior art keywords
pharmaceutical combinations
combinations containing
containing tiotropium
tiotropium
respiratory diseases
Prior art date
Application number
TR2010/00622A
Other languages
English (en)
Inventor
Bi̇lgi̇ç Mahmut
Original Assignee
Bi̇lgi̇ç Mahmut
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bi̇lgi̇ç Mahmut filed Critical Bi̇lgi̇ç Mahmut
Priority to TR2010/00622A priority Critical patent/TR201000622A2/tr
Priority to PCT/TR2011/000022 priority patent/WO2011093820A2/en
Publication of TR201000622A2 publication Critical patent/TR201000622A2/tr
Priority to US13/531,972 priority patent/US8834931B2/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/439—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom the ring forming part of a bridged ring system, e.g. quinuclidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/145—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic compounds

Abstract

Solunum yolları hastalıklarında kullanılmak üzere, formoterol, flutikazon ve tiotropium ve/veya bunların farmasötik açıdan kabul edilebilen türevlerini içeren ilaç ve bu ilacın astım, alerjik rinit ve KOAH başta olmak üzere solunum yollarıhastalıklarının semptomatik ve/veya profilaktik tedavisinde kullanımı.
TR2010/00622A 2009-12-25 2010-01-28 Tiotropyum içeren farmasötik kombinasyonlar. TR201000622A2 (tr)

Priority Applications (3)

Application Number Priority Date Filing Date Title
TR2010/00622A TR201000622A2 (tr) 2010-01-28 2010-01-28 Tiotropyum içeren farmasötik kombinasyonlar.
PCT/TR2011/000022 WO2011093820A2 (en) 2010-01-28 2011-01-28 A pharmaceutical combination comprising tiotropium
US13/531,972 US8834931B2 (en) 2009-12-25 2012-06-25 Dry powder formulation containing tiotropium for inhalation

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
TR2010/00622A TR201000622A2 (tr) 2010-01-28 2010-01-28 Tiotropyum içeren farmasötik kombinasyonlar.

Publications (1)

Publication Number Publication Date
TR201000622A2 true TR201000622A2 (tr) 2011-08-22

Family

ID=43928910

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2010/00622A TR201000622A2 (tr) 2009-12-25 2010-01-28 Tiotropyum içeren farmasötik kombinasyonlar.

Country Status (2)

Country Link
TR (1) TR201000622A2 (tr)
WO (1) WO2011093820A2 (tr)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2013109209A1 (en) * 2012-01-16 2013-07-25 Mahmut Bilgic Dry powder formulations comprising fluticasone
EP2804591A2 (en) * 2012-01-16 2014-11-26 Mahmut Bilgic Preparation of dry powder formulations comprising tiotropium
WO2013109219A1 (en) * 2012-01-16 2013-07-25 Mahmut Bilgic Dry powder formulations comprising tiotropium and carmoterol
US8765725B2 (en) 2012-05-08 2014-07-01 Aciex Therapeutics, Inc. Preparations of hydrophobic therapeutic agents, methods of manufacture and use thereof
HUE050993T2 (hu) 2012-05-08 2021-01-28 Nicox Ophthalmics Inc Flutikazon-propionát polimorf formája
JP6091862B2 (ja) * 2012-11-26 2017-03-08 クリニプロ株式会社 吸入用パウダーの製造方法
US9815865B2 (en) 2013-01-07 2017-11-14 Nicox Ophthalmics, Inc. Preparations of hydrophobic therapeutic agents, methods of manufacture and use thereof
GB201409603D0 (en) * 2014-05-30 2014-07-16 Teva Pharmaceuticals Europ B V An inhalable medicament

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0009591D0 (en) * 2000-04-18 2000-06-07 Glaxo Group Ltd Medical combinations
DE10130371A1 (de) * 2001-06-23 2003-01-02 Boehringer Ingelheim Pharma Neue Arzneimittelkompositionen auf der Basis von Anticholinergika, Corticosteroiden und Betamimetika
SE0303571D0 (sv) * 2003-12-03 2003-12-22 Microdrug Ag Medical product for moisture-sensitive medicaments

Also Published As

Publication number Publication date
WO2011093820A3 (en) 2012-02-23
WO2011093820A2 (en) 2011-08-04

Similar Documents

Publication Publication Date Title
TR201000680A2 (tr) Tiotropyum, formoterol ve budesonid içeren farmasötik bileşimler
TR201000623A2 (tr) Yeni tiotropyum kombinasyonu.
TR201000622A2 (tr) Tiotropyum içeren farmasötik kombinasyonlar.
TR201000681A2 (tr) İnhalasyon yoluyla alınan kuru toz formülasyonları.
EP2749280A3 (en) Combination of glycopyrronium and formoterol
JP2010132695A5 (tr)
WO2014064410A8 (en) Pharmaceutical composition
EA201690541A1 (ru) Сухой порошковый препарат, содержащий ингибитор фосфодиэстеразы
GB201205632D0 (en) Method and apparatus
TR201000733A2 (tr) Flutikazon, tiotropyum ve sodyum kromoglikat içeren farmasötik bileşimler.
IL213959A (en) Inhaled corticosteroid gas fog spray for use in the treatment of patients with severe and uncontrolled asthma
WO2014016548A3 (en) Pharmaceutical composition comprising olodaterol and one or more further active pharmaceutical ingredient
CO7160008A2 (es) Derivados de estra- 1,3,5(10),16- tetraeno 3-sustituidos, métodos para su preparación, prepara-ciones farmaceúticas que los contienen, así como su uso para la preparación de medicamentos
AR100368A1 (es) Tratamiento de trastornos respiratorios
EA201201397A1 (ru) Ингалятор, содержащий расслаиваемую блистерную упаковку
EA201201391A1 (ru) Ингалятор
EA201201390A1 (ru) Кнопочное устройство мундштука ингалятора сухого порошка
WO2011093818A3 (en) Pharmaceutical compositions comprising salmeterol and fluticasone
WO2011093815A3 (en) Pharmaceutical compositions comprising formoterol and mometasone
EA201201389A1 (ru) Ингалятор, создающий турбулентность
GEP201606577B (en) Nasal pharmaceutical formulation
EA201201394A1 (ru) Ингалятор для доставки лекарственного средства в виде сухого порошка
TR201207225A2 (tr) Bir inhalasyon formülasyonu.
WO2011093811A3 (en) Pharmaceutical preparations comprising formoterol and fluticasone
TR201207226A2 (tr) Yeni inhalasyon aerosol formülasyonlar.